FDA Adverse Event
Injury
Summary report: N
HEARTMATE 2
MDR report key: 16485473
·
Received March 6, 2023
Report
- Report Number
- 16485473
- Event Type
- Injury
- Date Received
- March 6, 2023
- Date of Event
- December 11, 2021
- Report Date
- February 15, 2022
- Manufacturer
- THORATEC CORPORATION
- Product Code
- DSQ
- Adverse Event
- Yes
- Report Source
- User Facility report
- Reporter Location
- NC, US
- Reporter Occupation
- NURSE
- Health Professional
- Yes
Narratives
Description of Event or Problem · 0
PATIENT ADMITTED (B)(6) 2021. ON (B)(6) 2021 PT DEVELOPED INCREASED LOH AND DARK URINE. (NORMAL LOH RANGE 400-600). AST, ALT AND BILI WITHIN NORMAL RANGES. PT NOT ON HEPARIN AND ASPIRIN. ON LOW DOSE COUMADIN PRIOR TO "12/05" DUE TO BLEEDING ISSUES. STARTED HEPARIN AND ASPIRIN AND CONTINUED COUMADIN. ON (B)(6) LOH 736. ON (B)(6) PTT 59.5 AND INR 1.8. ON (B)(6) URINE RETURNED TO YELLOW COLOR AND LOH DECREASING.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1549351 | HEARTMATE 2 | LEFT VENTRICULAR ASSIST DEVICE | DSQ | THORATEC CORPORATION |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 66 YR | Male | Required Intervention |